Simulations Plus, Inc. stock (NASDAQ:SLP – received rating) hit a fresh 52-week high during midday trade on Friday. The company traded as high as $66.81 and last at $66.77 with volume of 2303 shares. The stock had previously closed at $66.28.
Analyst upgrades and downgrades
SLP has been the subject of a number of recent research reports. Craig Hallum increased his price target on Simulations Plus stock to $60.00 from $55.00 and issued a research note on Thursday, July 7, with a “buy” rating of the stock. TheStreet upgraded shares of Simulations Plus from a “c+” rating to a “b-” rating in a research note on Friday, July 22nd.
Simulations plus value for money
The company has a market cap of $1.35 billion, a P/E of 117.34 and a beta of 0.42. The stock’s 50-day moving average is $53.16 and the two-hundred-day moving average is $47.29.
Simulations Plus (NASDAQ:SLP – received rating) last released its earnings results on Wednesday, July 6th. The tech company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.17 by $0.03. The company had revenue of $14.96 million for the quarter, compared to the consensus estimate of $14.33 million. Simulations Plus had a net margin of 22.74% and a return on equity of 6.91%. The company’s quarterly revenue increased 17.1% year over year. In the same quarter last year, the company generated earnings per share of $0.18. As a group, equities analysts expect Simulations Plus, Inc. to post 0.64 EPS for the year to date.
Simulations Plus announces dividend
The company also recently announced a quarterly dividend, which was paid on Monday, August 1st. Investors of record received a dividend of $0.06 on Monday July 25th. The ex-dividend date of this dividend was Friday July 22nd. That equates to an annualized dividend of $0.24 and a dividend yield of 0.36%. The payout ratio of Simulations Plus is currently 42.11%.
Insider buying and selling
In other news, director Walter S. Woltosz sold 20,000 shares of the company’s shares in a transaction that took place on Wednesday, July 27. The shares sold at an average price of $61.19 for a total value of $1,223,800.00. Upon completion of the transaction, the Director now owns 4,117,634 shares of the Company, valued at $251,958,024.46. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed here this link. In related news, on Tuesday, June 28, Director Walter S. Woltosz sold 17,461 shares of the company’s stock in a transaction. The shares sold at an average price of $48.00 for a total value of $838,128.00. Following the sale, the Director now directly owns 4,140,173 shares of the Company, valued at approximately $198,728,304. The transaction was disclosed in a legal filing with the Securities & Exchange Commission available at this hyperlink. Also on Wednesday, July 27, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction. The shares were sold at an average price of $61.19 for a total transaction of $1,223,800.00. Upon completion of the sale, the Director now directly owns 4,117,634 shares of the Company, valued at $251,958,024.46. Disclosure for this sale can be found here. Over the past three months, insiders sold 57,461 shares of the company’s stock valued at $3,021,728. 23.08% of the shares are owned by company insiders.
Institutional investors rely on Simulations Plus
Several institutional investors have recently added to or reduced their stakes in SLP. Allspring Global Investments Holdings LLC acquired a new $32,000 stake in Simulations Plus during Q1. Fifth Third Bancorp increased its position in Simulations Plus by 52.5% in the fourth quarter. Fifth Third Bancorp now owns 808 shares of the $38,000 tech company after buying another 278 shares last quarter. KBC Group NV acquired a new stake in Simulations Plus valued at approximately USD 68,000 in the second quarter. Hardy Reed LLC acquired a new interest in Simulations Plus valued at approximately $113,000 during the first quarter. Eventually, Mitsubishi acquired UFJ Kokusai Asset Management Co. Ltd. a new investment in Simulations Plus valued at approximately $166,000 in Q1. 73.48% of the shares are owned by institutional investors.
Company profile of Simulations Plus
Simulations Plus, Inc develops drug discovery and development software for modeling, simulation and prediction of molecular properties using artificial intelligence and machine learning based technologies worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym and Lixoft.
Selected Stories
Receive daily news and reviews for Simulations Plus – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Simulations Plus and related companies with MarketBeat.com’s FREE daily email newsletter.
